enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Oxymetazoline - Wikipedia

   en.wikipedia.org/wiki/Oxymetazoline

   Oxymetazoline, sold under the brand name Afrin among others, is a topical decongestant and vasoconstrictor medication. It is available over-the-counter as a nasal spray to treat nasal congestion and nosebleeds, as eye drops to treat eye redness due to minor irritation, and (in the United States) as a prescription topical cream to treat persistent facial redness due to rosacea in adults.

3. Rhinitis medicamentosa - Wikipedia

   en.wikipedia.org/wiki/Rhinitis_medicamentosa

   Rhinitis medicamentosa (or RM, also known as rebound congestion) is a condition of rebound nasal congestion suspected to be brought on by extended use of topical decongestants (e.g., oxymetazoline, phenylephrine, xylometazoline, and naphazoline nasal sprays) and certain oral medications (e.g., sympathomimetic amines and various 2-imidazolines) that constrict blood vessels in the lining of the ...

4. Xylometazoline - Wikipedia

   en.wikipedia.org/wiki/Xylometazoline

   Xylometazoline, also spelled xylomethazoline, is a medication used to reduce symptoms of nasal congestion, allergic rhinitis, and sinusitis. [2] It is used directly in the nose as a spray or drops. [3] Side effects include trouble sleeping, irritation of the nose, nausea, nosebleed (3%), period pain (10%) and headache (3%).

5. FDA approves first nasal spray to treat dangerous allergic ...

   www.aol.com/lifestyle/fda-approves-first-nasal...

   ARS didn’t immediately disclose a list price, but said it would make the spray available through certain discount programs for about $200 per two-pack. Insurance plans must still decide whether ...

6. Propylhexedrine - Wikipedia

   en.wikipedia.org/wiki/Propylhexedrine

   Propylhexedrine is used to treat acute nasal congestion related to the common cold, allergies, and hay fever. For nasal congestion, the dosage is listed as four inhalations (two inhalations per nostril) every two hours for adults and children 6–12 years of age. Each inhalation delivers 0.4 to 0.5 mg (400 to 500 μg) in 800 mL of air.

7. What is Neffy? FDA approves first nasal spray to treat severe ...

   www.aol.com/neffy-fda-approves-first-nasal...

   The nasal spray will officially hit the market in eight weeks. ARS Pharmaceuticals is reportedly planning to file for FDA approval for a lower-dose version of Neffy, which would work for children ...